State AL
Clinical Trials in Alabama
Recruiting clinical trials with at least one study location in Alabama. Data updated daily from ClinicalTrials.gov.
Top Conditions in Alabama
NCT07136012 Phase 3
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a)...
Condition
Cardiovascular Disease
Enrollment
11,000 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT04093388 N/A
Recruiting
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Lo...
Condition
Cervical Cancer
Enrollment
250 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06824987 Phase 2
Recruiting
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants...
Condition
APOL1-Mediated Kidney Disease
Enrollment
96 pts
Location
United States, United Kingdom
Sponsor
AstraZeneca
NCT07489105 N/A
Recruiting
Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function
Condition
Heart Failure
Enrollment
20 pts
Location
United States
Sponsor
Auburn University
NCT06752668 Phase 2
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Condition
Narcolepsy Type 1
Enrollment
96 pts
Location
United States, Canada
Sponsor
Centessa Pharmaceuticals (UK)
NCT06267391 N/A
Recruiting
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in ...
Condition
Type 2 Diabetes Mellitus
Enrollment
264 pts
Location
United States, Australia
Sponsor
Endogenex, Inc.
NCT06682143 N/A
Recruiting
The Effects of Virtual Reality Greenspace on Stress Among Adults With Mobility I...
Condition
Mobility Impairments
Enrollment
30 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06565390 N/A
Recruiting
Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Re...
Condition
Emergencies
Enrollment
700 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT01073475 N/A
Recruiting
Maternal Newborn Health Registry
Condition
Pregnancy Outcome Trends in Low-resource Geographic Areas
Enrollment
950,000 pts
Location
United States, Bangladesh, Democratic Republic of the Congo
Sponsor
NICHD Global Network for Women
NCT06164730 Phase 1
Recruiting
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature...
Condition
Heterozygous Familial Hypercholesterolemia
Enrollment
85 pts
Location
United States, Australia, Canada
Sponsor
Verve Therapeutics, Inc.
NCT05547165 N/A
Recruiting
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low W...
Condition
Ductus Arteriosus, Patent
Enrollment
240 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT06770998 N/A
Recruiting
A Study of a Novel EEG Neurofeedback System for PTSD Treatment
Condition
Stress Disorders, Post-Traumatic
Enrollment
250 pts
Location
United States
Sponsor
Foundation for Atlanta Veteran
NCT06329401 Phase 2
Recruiting
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With ...
Condition
Progressive Pulmonary Fibrosis
Enrollment
375 pts
Location
United States, Argentina, Australia
Sponsor
Avalyn Pharma Inc.
NCT06939478 N/A
Recruiting
AI Powered Mapping Technology for Identifying Arrhythmias
Condition
Arrhythmias, Cardiac
Enrollment
110 pts
Location
United States
Sponsor
Heart Rhythm Clinical and Rese
NCT07256392 Phase 3
Recruiting
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Particip...
Condition
Chronic Spontaneous Urticaria
Enrollment
1,370 pts
Location
United States
Sponsor
Celldex Therapeutics
NCT06504446 Phase 2
Recruiting
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With...
Condition
Refractory or Unexplained Chronic Cough
Enrollment
455 pts
Location
United States, Belgium, Canada
Sponsor
Nocion Therapeutics
NCT07103746 Phase 2
Recruiting
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Condition
Autoimmune Disorders
Enrollment
30 pts
Location
United States
Sponsor
National Institute of Allergy
NCT07227246 Phase 3
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Condition
Intracerebral Hemorrhage
Enrollment
350 pts
Location
United States, Canada, Germany
Sponsor
Joseph Broderick, MD
NCT06007053 N/A
Recruiting
Retraining and Control Therapy (ReACT) R33 Phase
Condition
Convulsion, Non-Epileptic
Enrollment
160 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05685433 N/A
Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Eval...
Condition
Overactive Bladder
Enrollment
200 pts
Location
United States
Sponsor
Valencia Technologies Corporat
NCT05685745 N/A
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Condition
Infant, Extremely Premature
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
The University of Texas Health
NCT06502951 N/A
Recruiting
Manipulation and Dry Needling in Patients With Cervicogenic Headache and WAD II
Condition
Cervicogenic Headache
Enrollment
120 pts
Location
United States
Sponsor
Alabama Physical Therapy & Acu
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05602194 Phase 3
Recruiting
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy f...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
440 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06105684 Phase 2
Recruiting
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Bre...
Condition
Metastatic Breast Cancer
Enrollment
40 pts
Location
United States
Sponsor
University of Alabama at Birmi